Levamisole was mainly prescribed to treat:

• Mild parasitic worm infections

Because these conditions are generally not severe, the EMA determined:
 The neurological risks are too high compared to the benefits

What Happens Now?

• All levamisole-based medicines will be removed across the EU
• National health authorities will implement the recall
• Updated lists of affected medications have been issued

Advice for Patients

If you are taking or have taken levamisole:

• Contact your doctor or pharmacist
• Ask about safe alternatives
• Do not panic—cases are rare, but awareness is important

Key Takeaway

This decision highlights an important principle in medicine:

 A drug is only approved as long as its benefits outweigh its risks

In the case of levamisole:

• Risks = neurological complications
• Benefits = treatment of mild conditions

 Result: Withdrawal from the market

Note:
This information is for awareness only and does not replace medical advice. Always consult a healthcare professional for personal guidance.